Ultra Clean Holdings, Inc. (UCTT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ:UCTT). Investors who purchased Ultra Clean securities prior to May 6, 2024, and continue to hold to the present, are encouraged […]

Pomerantz LLP Advises Shareholders of Class Action Filing Involving Quantum Biopharma Ltd. – QNTM

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who

PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS" or "the Company") (NYSE:PACS). Investors who purchased PACS securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain

Pomerantz LLP Informs Shareholders of Class Action Filing Against Klarna Group PLC – KLAR

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Klarna Group PLC ("Klarna" or the "Company") (NYSE:KLAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Pomerantz LLP Informs Shareholders of Securities Class Action Against Coupang, Inc. – CPNG

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Coupang, Inc. ("Coupang" or the "Company") (NYSE:CPNG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Trip.com Group Limited (TCOM) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Trip.com Group Limited ("Trip.com" or "the Company") (NASDAQ:TCOM). Investors who purchased Trip.com securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TCOM.

Bronstein, Gewirtz & Grossman, LLC Encourages Synopsys, Inc. (SNPS) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 18, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Synopsys, Inc. ("Synopsys" or "the Company") (NASDAQ:SNPS). Investors who purchased Synopsys securities prior to December 4, 2024, and continue to hold to the present, are encouraged to obtain additional

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gauzy Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GAUZ

(NasdaqGM:GAUZ), NEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), of the important February 6, 2026 lead plaintiff deadline. SO WHAT: If you

Scroll to Top